Log in to save to my catalogue

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disea...

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2641718426

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease

About this item

Full title

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease

Publisher

London: Nature Publishing Group UK

Journal title

The pharmacogenomics journal, 2016-08, Vol.16 (4), p.326-335

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Short-acting β
2
-agonist bronchodilators are the most common medications used in treating chronic obstructive pulmonary disease (COPD). Genetic variants determining bronchodilator responsiveness (BDR) in COPD have not been identified. We performed a genome-wide association study (GWAS) of BDR in 5789 current or former smokers with COPD in on...

Alternative Titles

Full title

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2641718426

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2641718426

Other Identifiers

ISSN

1470-269X

E-ISSN

1473-1150

DOI

10.1038/tpj.2015.65

How to access this item